Pfizer PFE Liability For Uncertain Tax Positions Noncurrent
Liability For Uncertain Tax Positions Noncurrent at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:LiabilityForUncertainTaxPositionsNoncurrent.
The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pfizer's liability for uncertain tax positions noncurrent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pfizer's liability for uncertain tax positions noncurrent?
- Pfizer (PFE) reported liability for uncertain tax positions noncurrent of $3.71B in Q1 2026.
- How has Pfizer's liability for uncertain tax positions noncurrent changed year-over-year?
- Pfizer's liability for uncertain tax positions noncurrent decreased by 35.3% year-over-year, from $5.72B to $3.71B.
- What is the long-term trend for Pfizer's liability for uncertain tax positions noncurrent?
- Over 5 years (2020 to 2025), Pfizer's liability for uncertain tax positions noncurrent has grown at a -20.8% compound annual growth rate (CAGR), from $11.56B to $3.59B.